ClinicalTrials.Veeva

Menu

Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases

G

Gulseren Demir Karakilic

Status

Completed

Conditions

Healthy Controls
Psoriatic Arthritis
Knee Osteoarthritis
Ankylosing Spondylitis
Rheumatoid Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT07054749
2024-GOKAEK-2413_2024.11.20_17

Details and patient eligibility

About

This study aims to evaluate digital health competencies in individuals with rheumatic and degenerative joint diseases. Specifically, it assesses e-health literacy and artificial intelligence literacy, which refer to individuals' ability to access, understand, and utilize online health information and AI-based health technologies. Participants include patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, knee osteoarthritis, and healthy volunteers. The study also examines how these competencies are associated with demographic variables, anxiety, depression, and functional status. Findings may contribute to improving digital health strategies for patients with chronic musculoskeletal conditions.

Full description

Digital technologies and artificial intelligence (AI) are becoming increasingly integrated into healthcare systems. However, the ability of patients to effectively access and use these technologies varies depending on multiple factors such as education level, health status, and psychological well-being. This cross-sectional study aims to measure two key competencies: e-health literacy (the ability to seek, find, understand, and appraise online health information) and artificial intelligence literacy (understanding and engaging with AI-supported health tools).

The study will recruit three groups: individuals with inflammatory rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis), individuals with degenerative joint disease (knee osteoarthritis), and healthy controls. All participants will complete standardized self-report questionnaires, including the E-Health Literacy Scale (eHEALS), the Artificial Intelligence Literacy Scale (AILS), the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI), and the Health Assessment Questionnaire (HAQ).

The primary aim is to compare digital literacy levels across groups and examine correlations with socio-demographic characteristics and mental health indicators. The results are expected to inform clinical strategies and patient education programs aimed at improving engagement with digital health services, particularly in patients with chronic rheumatic conditions.

Enrollment

201 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age between 18 and 65 years

Adequate cognitive function and literacy

Ability to provide written informed consent

For RA group: Diagnosis of rheumatoid arthritis based on ACR 2010 criteria

For AS group: Diagnosis of ankylosing spondylitis based on Modified New York criteria

For PSA group: Diagnosis of psoriatic arthritis based on CASPAR criteria

For OA group: Clinical and radiological diagnosis of knee osteoarthritis with symptoms ≥6 months

For healthy controls: No known chronic diseases or complaints

Exclusion criteria

Cognitive impairment or illiteracy

Unwillingness to participate

Presence of multiple rheumatic diseases

Major psychiatric disorder or neurodegenerative disease

Use of assistive digital devices that influence e-health literacy independently

Trial design

201 participants in 3 patient groups

Patient group
Description:
Inclusion criteria for the Rheumatoid arthritis group were: meeting the 2010 American College of Rheumatology (ACR) classification criteria for Rheumatoid arthritis , aged 18-65 years, preserved cognitive function, literacy, and willingness to participate. The ankylosing spondylitis group included individuals who met the Modified New York criteria for ankylosing spondylitis and fulfilled the same cognitive, literacy, and age requirements. Similarly, the psoriatic arthritis group consisted of patients meeting the the Classification of Psoriatic Arthritis (CASPAR) criteria classification criteria, aged 18-65, with adequate cognition and literacy, and who consented to participate.
The knee osteoarthritis control group
Description:
The knee osteoarthritis control group included individuals who presented to the same clinic with chronic knee pain (≥6 months), were diagnosed with knee OA based on clinical and radiological findings, and matched the IRD group by age and gender using frequency matching. They also had adequate cognitive and literacy levels and provided consent.
The healthy control group
Description:
The healthy control group was composed of community-dwelling individuals without any diagnosed chronic disease or complaints, matched to the patient group in terms of age and gender, with preserved cognitive function, literacy, and voluntary participation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems